Mr. Boris Jordan reports

CURALEAF ANNOUNCES APPOINTMENT OF TORSTEN GREIF TO BOARD OF DIRECTORS

Curaleaf Holdings Inc. has appointed Torsten Greif to the Curaleaf board of directors.

Mr. Greif is a respected entrepreneur and one of the founders of Four 20 Pharma GmbH, Curaleaf's flagship German brand. With deep expertise in cannabis cultivation, regulatory strategy and brand development, he has been instrumental in positioning Four 20 Pharma as a leading premium cannabis provider in Germany's emerging medical cannabis market. Under his leadership, the company achieved a majority stake sale to Curaleaf, underscoring his strategic vision, cross-industry approach and ability to find success in the evolving German cannabis market.

"We're thrilled to welcome Torsten to the global Curaleaf leadership team," said Boris Jordan, chairman and chief executive officer of Curaleaf. "Torsten's vision, deep local knowledge and proven ability to execute in complex regulatory environments will be tremendous assets as we continue to scale Curaleaf's European operations. His leadership reflects our commitment to building best-in-class cannabis businesses around the world."

"I'm honoured to join Curaleaf at this important stage of the company's international expansion," said Mr. Greif. "The European cannabis market is evolving rapidly, and I look forward to partnering with our talented teams to deliver high-quality, EU GMP certified medical cannabis to Germany and beyond. Curaleaf's global platform will enable us to accelerate innovation and contribute to the broader legitimization of cannabis in Europe."

Mr. Greif's appointment reinforces Curaleaf's commitment to strategic leadership and operational excellence as the company further integrates its European footprint and prepares for long-term growth across regulated markets.

About Curaleaf Holdings Inc.

Curaleaf is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the company and its brands, including Curaleaf, Select, Grassroots, Find, Dark Heart and Anthem, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF.

We seek Safe Harbor.